Tag: mAb stability testing

Case Study: Protocol Design for a Temperature-Sensitive Biologic

Temperature-sensitive biologics present unique challenges during stability testing and protocol design. This case study explores the comprehensive planning and execution of a stability study for a recombinant monoclonal antibody (mAb) intended for subcutaneous injection. The molecule in question demonstrated a narrow temperature tolerance range, significant sensitivity to agitation, and a high aggregation risk. These properties…

Protocols and Reports, Stability Study Protocols for Different Drug Types

How ICH Stability Guidelines Differ for Biologics vs. Small Molecules

In pharmaceutical development, understanding how stability testing requirements differ between biologics and small molecule drugs is crucial for regulatory compliance. While both product types must meet ICH stability expectations, their testing parameters, degradation risks, and documentation differ significantly. This tutorial-style guide highlights the practical distinctions between ICH guidelines like Q1A and Q5C, with a focus…

ICH Stability Guidelines (Q1A–Q1E, Q8, Q9, etc.), Regulatory Guidelines